scholarly article | Q13442814 |
P50 | author | Michiaki Kubo | Q42316443 |
Richard Weinshilboum | Q52447985 | ||
Bingshu E. Chen | Q56027887 | ||
Krishna R Kalari | Q57034862 | ||
Erin E Carlson | Q57034978 | ||
Vered Stearns | Q87723624 | ||
Yoichi Furukawa | Q88631928 | ||
Matthew J Ellis | Q88724457 | ||
Liewei Wang | Q89121645 | ||
James N Ingle | Q89668737 | ||
Poulami Barman | Q90864335 | ||
Yukihide Momozawa | Q92225382 | ||
Matthew P Goetz | Q95259846 | ||
P2093 | author name string | Paul E Goss | |
Fang Xie | |||
Kathleen I Pritchard | |||
Judith-Anne W Chapman | |||
Lois E Shepherd | |||
P2860 | cites work | Mechanisms of Endocrine Resistance in Breast Cancer | Q36851417 |
Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression | Q36924856 | ||
Long noncoding RNAs and the genetics of cancer. | Q36959100 | ||
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention | Q37009636 | ||
Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway | Q37515474 | ||
Biological determinants of endocrine resistance in breast cancer | Q37585095 | ||
Mechanisms of aromatase inhibitor resistance. | Q38439266 | ||
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. | Q38991643 | ||
The Inescapable Influence of Noncoding RNAs in Cancer | Q39927058 | ||
Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole | Q40248483 | ||
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer. | Q50520130 | ||
A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene | Q72710299 | ||
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system | Q80358653 | ||
A genome-wide association study identifies protein quantitative trait loci (pQTLs) | Q21145048 | ||
Population structure and eigenanalysis | Q21145248 | ||
Complete sequencing and characterization of 21,243 full-length human cDNAs | Q21735916 | ||
The landscape of long noncoding RNAs in the human transcriptome | Q22122065 | ||
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Q24607308 | ||
Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA | Q27011221 | ||
Genome regulation by long noncoding RNAs. | Q27691812 | ||
Cancer statistics, 2015 | Q27860576 | ||
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data | Q27860742 | ||
Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
Ligand-independent coactivation of ERalpha AF-1 by steroid receptor RNA activator (SRA) via MAPK activation | Q28203998 | ||
A framework for variation discovery and genotyping using next-generation DNA sequencing data | Q29547262 | ||
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3 | Q29614852 | ||
Score tests for association between traits and haplotypes when linkage phase is ambiguous | Q29616281 | ||
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration | Q30514241 | ||
From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline | Q30872351 | ||
Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells | Q33614071 | ||
Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. | Q33962806 | ||
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics | Q34265045 | ||
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials | Q34486930 | ||
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors | Q34488758 | ||
Long intergenic noncoding RNAs: new links in cancer progression | Q34676547 | ||
Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. | Q34712217 | ||
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen | Q35006860 | ||
The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation. | Q35117450 | ||
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials | Q35186747 | ||
A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation. | Q35574894 | ||
LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis | Q36179588 | ||
Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation | Q36632405 | ||
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis | Q36643119 | ||
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial | Q36729512 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacogenomics | Q1152227 |
P304 | page(s) | 7012-7023 | |
P577 | publication date | 2016-10-10 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy | |
P478 | volume | 76 |
Q39453727 | 'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling. |
Q45943221 | Breast cancer: The translation of big genomic data to cancer precision medicine. |
Q44517598 | Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling |
Q51739091 | Functional Variants in Linc-ROR are Associated with mRNA Expression of Linc-ROR and Breast Cancer Susceptibility. |
Q39362053 | Genomic Insight into the Role of lncRNA in Cancer Susceptibility |
Q38739248 | Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients. |
Q41577349 | Immune Mediator Pharmacogenomics: TCL1A SNPs and Estrogen-Dependent Regulation of Inflammation |
Q57106074 | Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer |
Q47258279 | Long Noncoding RNA in Cancer: Wiring Signaling Circuitry |
Q99419118 | Managing therapeutic resistance in breast cancer: from the lncRNAs perspective |
Q47755674 | Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study |
Q96306239 | Significance of Single-Nucleotide Variants in Long Intergenic Non-protein Coding RNAs |
Q89449268 | Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction |
Q88313233 | TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune |
Q51415655 | TCL1A, a novel transcription factor and a co-regulator of NF-кB p65: SNP and estrogen-dependence. |
Q94571038 | The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update |
Q64079299 | The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1 |
Q93235559 | The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth |
Q90435884 | The network of non-coding RNAs and their molecular targets in breast cancer |
Q90023785 | WITHDRAWN: Single nucleotide polymorphism, a putative driver for the role of long intergeneric non-coding RNA |